11/04/2019

IVI acquires GCLP certification from Korean Ministry of Food and Drug Safety

Institute expected to increase contributions to vaccine development activities worldwide   November 1, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), an international organization for vaccine development and delivery headquartered in Seoul, has been granted Good Clinical Laboratory Practice (GCLP) certification by […]
11/12/2019

SAG meeting held at IVI followed by second face-to-face BOT meeting of the year

On November 12, 2019, IVI’s Scientific Advisory Group (SAG) gathered at IVI headquarters in Seoul, Korea for an annual two-day meeting of project presentations, insightful Q&As, and critical engagement. Following the SAG days, the IVI Board of Trustees met for their second face-to-face meeting of […]
11/13/2019

IVI to Accelerate Efforts in iNTS Vaccine Development

An award from the Wellcome Trust’s Affordable Innovations for Global Health Flagship will support IVI’s development and selection of potential vaccine candidates There is currently no vaccine available to protect against invasive non-typhoidal salmonella (iNTS)   November 13, 2019 – SEOUL, South Korea – The […]
11/24/2019

World Antibiotic Awareness Week 2019

Accelerate vaccines. Decelerate AMR.   Every November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices to avoid its further emergence and spread. This year, IVI ran a social media campaign to raise awareness specifically around […]